Mark Louis Friedman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Louis Friedman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Louis Friedman. Mark Louis Friedman is Vice President of RA/QA in AxoGen, Inc. ($LECT) and VP Regulatory Affairs & Policy in Axogen, Inc. ($LECT) and VP, Regulatory & Quality in Axogen, Inc. ($LECT) and VP,Regulatory & Quality in AxoGen, Inc. ($LECT).
Latest Insider Trading Transactions of Mark Louis Friedman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affai ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
| Mar 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affai ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
| Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Payment of Exercise | F | 18.71 | 361 | 6,754 | 13,936 | 14.3 K to 13.9 K (-2.53 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Grant | A | 0.00 | 1,181 | 0 | 14,297 | 13.1 K to 14.3 K (+9.00 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Payment of Exercise | F | 18.70 | 590 | 11,033 | 13,116 | 13.7 K to 13.1 K (-4.30 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Grant | A | 0.00 | 1,930 | 0 | 13,706 | 11.8 K to 13.7 K (+16.39 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | S | 17.81 | 567 | 10,098 | 11,124 | 11.7 K to 11.1 K (-4.85 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 2,300 | 0 | 11,691 | 9.4 K to 11.7 K (+24.49 %) |
| Dec 22 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | S | 16.42 | 96 | 1,576 | 8,893 | 9 K to 8.9 K (-1.07 %) |
| Dec 22 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 375 | 0 | 8,989 | 8.6 K to 9 K (+4.35 %) |
| Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 3.67 | 3,187 | 11,696 | 0 | |
| Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 4.81 | 625 | 3,006 | 0 | |
| Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 3.67 | 3,187 | 11,696 | 8,614 | 5.4 K to 8.6 K (+58.72 %) |
| Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 4.81 | 625 | 3,006 | 5,427 | 4.8 K to 5.4 K (+13.02 %) |
| Mar 18 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Mar 18 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
| Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 14.68 | 351 | 5,153 | 4,802 | 5.2 K to 4.8 K (-6.81 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 1,181 | 0 | 5,153 | 6.3 K to 5.2 K (-18.65 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 14.68 | 573 | 8,412 | 3,972 | 4.5 K to 4 K (-12.61 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 1,930 | 0 | 4,545 | 2.6 K to 4.5 K (+73.80 %) |
| Dec 20 2019 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 16.73 | 183 | 3,062 | 2,127 | 2.3 K to 2.1 K (-7.92 %) |
| Dec 20 2019 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 750 | 0 | 2,310 | 1.6 K to 2.3 K (+48.08 %) |
| May 17 2019 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | D | 21.14 | 67,952 | 1,436,594 | 1,560 | 69.5 K to 1.6 K (-97.76 %) |
| Feb 19 2019 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 17.57 | 573 | 10,068 | 69,512 | 70.1 K to 69.5 K (-0.82 %) |
| Feb 19 2019 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 1,930 | 0 | 70,085 | 68.2 K to 70.1 K (+2.83 %) |
| Dec 31 2018 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
| Dec 31 2018 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 19.17 | 18,500 | 354,645 | 18,500 | |
| Dec 20 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
| Dec 20 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 27.00 | 9,000 | 243,000 | 9,000 | |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 1.07 | 16,829 | 18,007 | 0 | |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 4.81 | 4,375 | 21,044 | 625 | |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 3.67 | 5,313 | 19,499 | 3,187 | |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 5.45 | 1,250 | 6,813 | 3,750 | |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 2.74 | 40,000 | 109,600 | 0 | |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 1.07 | 16,829 | 18,007 | 67,952 | 51.1 K to 68 K (+32.92 %) |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 4.81 | 4,375 | 21,044 | 51,123 | 46.7 K to 51.1 K (+9.36 %) |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 3.67 | 5,313 | 19,499 | 46,748 | 41.4 K to 46.7 K (+12.82 %) |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 5.45 | 1,250 | 6,813 | 41,435 | 40.2 K to 41.4 K (+3.11 %) |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 20.00 | 5,480 | 109,600 | 40,185 | 45.7 K to 40.2 K (-12.00 %) |
| Oct 26 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 2.74 | 40,000 | 109,600 | 45,665 | 5.7 K to 45.7 K (+706.09 %) |
| Jan 03 2017 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 8.95 | 25,000 | 223,750 | 25,000 | |
| May 31 2016 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 5.45 | 5,000 | 27,250 | 5,000 | |
| Dec 30 2015 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 5.09 | 10,000 | 50,900 | 10,000 | |
| Jan 06 2014 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | A | 4.81 | 5,000 | 24,050 | 67,494 | |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | M | 0.27 | 309 | 83 | 0 | |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | M | 0.27 | 601 | 162 | 0 | |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | M | 0.27 | 1,028 | 278 | 0 | |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | M | 0.27 | 3,727 | 1,006 | 0 | |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Buy | M | 0.27 | 309 | 83 | 5,665 | 5.4 K to 5.7 K (+5.77 %) |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Buy | M | 0.27 | 601 | 162 | 5,356 | 4.8 K to 5.4 K (+12.64 %) |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Buy | M | 0.27 | 1,028 | 278 | 4,755 | 3.7 K to 4.8 K (+27.58 %) |
| Jan 24 2012 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Buy | M | 0.27 | 3,727 | 1,006 | 3,727 | 0 to 3.7 K |
| Dec 20 2011 | LECT | AxoGen, Inc. | Friedman Mark Louis | Vice President of R ... | Option Exercise | A | 2.74 | 40,000 | 109,600 | 40,000 |
Page: 1